Cardiac problems in Friedreich’s Ataxia

Around 90% of patients afflicted with Friedreich’s Ataxia (FA) eventually show cardiac symptoms. In general, ataxia precedes the beginning of the cardiac symptoms. With most patients, it involves a cardiac disease called left ventricular hypertrophy. Left ventricular hypertrophy is an increase in the thickness of the wall and of the...

Continue reading

Clinical study on HDACIs… (2009)

By Guy D’Anjou, M.D. FRCPC Neurologist, Sainte-Justine Hospital Friedreich’s ataxia (FA) is one of the most frequent neurodegenerative diseases. Its clinical manifestations appear at a critical stage in the development of an individual and affect his autonomy and quality of life. A number of years ago it was discovered that...

Continue reading

Effects of buspirone on brain indoleamines and catecholamines in wild-type mice and Lurcher mutants (2000) [Funded by CAFA]

Reader, Tomas, A.; Ase, Ariel, R.; Le-Marec, Nathalie; Lalonde, Robert, 2000: Effects of buspirone on brain indoleamines and catecholamines in wild-type mice and Lurcher mutants. European Journal of Pharmacology 398(1): 41-51 [Funded by CAFA] Abstract The effects of a chronic serotoninergic stimulation on brain monoamine levels and metabolism were studied...

Continue reading